{ "company_number": "08354172", "name": "Douglas Neurosciences Limited", "url": "/company/08354172", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2013-01-09", "dissolved_on": null, "sic_codes": [ { "code": "86220", "description": "Specialists medical practice activities", "section": "Q", "section_name": "Human health and social work activities", "url": "/sic/86220" } ], "registered_address": { "id": 1240244, "url": "/address/1240244", "line1": "LIFFORD HALL LIFFORD LANE", "line2": "KINGS NORTON", "post_town": "BIRMINGHAM", "county": "WEST MIDLANDS", "country": "UNITED KINGDOM", "postcode": "B30 3JN" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08354172", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-10-31", "last_made_up": "2025-01-31", "category": "UNAUDITED ABRIDGED", "filings": [ { "url": "/company/08354172/accounts/2026-01-31", "pdf_url": "/company/08354172/accounts/2026-01-31.pdf", "made_up_date": "2026-01-31", "period_start": "2026-01-31", "period_end": "2026-01-31", "entity_name": "Douglas Neurosciences Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "17274.00", "debtors": "922.00", "cash_bank_in_hand": "123380.00", "current_assets": "124302.00", "creditors_due_within_one_year": "12246.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "112056.00", "total_assets_less_current_liabilities": "129330.00", "net_assets_liabilities": "129330.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "129230.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Bulk_Data-2026-08-08.zip" }, { "url": "/company/08354172/accounts/2025-01-31", "pdf_url": "/company/08354172/accounts/2025-01-31.pdf", "made_up_date": "2025-01-31", "period_start": "2025-01-31", "period_end": "2025-01-31", "entity_name": "Douglas Neurosciences Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "20192.00", "debtors": "981.00", "cash_bank_in_hand": "158870.00", "current_assets": "159851.00", "creditors_due_within_one_year": "49385.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "110466.00", "total_assets_less_current_liabilities": "130658.00", "net_assets_liabilities": "130658.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "130558.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2025.zip" }, { "url": "/company/08354172/accounts/2024-01-31", "pdf_url": "/company/08354172/accounts/2024-01-31.pdf", "made_up_date": "2024-01-31", "period_start": "2024-01-31", "period_end": "2024-01-31", "entity_name": "Douglas Neurosciences Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "22418.00", "debtors": "638.00", "cash_bank_in_hand": "139492.00", "current_assets": "140130.00", "creditors_due_within_one_year": "45942.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "94188.00", "total_assets_less_current_liabilities": "116606.00", "net_assets_liabilities": "116606.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "116506.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2024.zip" }, { "url": "/company/08354172/accounts/2023-01-31", "pdf_url": "/company/08354172/accounts/2023-01-31.pdf", "made_up_date": "2023-01-31", "period_start": "2023-01-31", "period_end": "2023-01-31", "entity_name": "Douglas Neurosciences Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "23234.00", "debtors": "725.00", "cash_bank_in_hand": "125190.00", "current_assets": "125915.00", "creditors_due_within_one_year": "44401.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "81514.00", "total_assets_less_current_liabilities": "104748.00", "net_assets_liabilities": "104748.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "104648.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2023.zip" }, { "url": "/company/08354172/accounts/2022-01-31", "pdf_url": "/company/08354172/accounts/2022-01-31.pdf", "made_up_date": "2022-01-31", "period_start": "2022-01-31", "period_end": "2022-01-31", "entity_name": "Douglas Neurosciences Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "24936.00", "debtors": "720.00", "cash_bank_in_hand": "100875.00", "current_assets": "101595.00", "creditors_due_within_one_year": "40789.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "60806.00", "total_assets_less_current_liabilities": "85742.00", "net_assets_liabilities": "85742.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "85642.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2022.zip" }, { "url": "/company/08354172/accounts/2021-01-31", "pdf_url": "/company/08354172/accounts/2021-01-31.pdf", "made_up_date": "2021-01-31", "period_start": "2021-01-31", "period_end": "2021-01-31", "entity_name": "Douglas Neurosciences Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "27540.00", "debtors": "664.00", "cash_bank_in_hand": "56660.00", "current_assets": "57324.00", "creditors_due_within_one_year": "8208.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "49116.00", "total_assets_less_current_liabilities": "76656.00", "net_assets_liabilities": "76656.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "76556.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2021.zip" }, { "url": "/company/08354172/accounts/2020-01-31", "pdf_url": "/company/08354172/accounts/2020-01-31.pdf", "made_up_date": "2020-01-31", "period_start": "2020-01-31", "period_end": "2020-01-31", "entity_name": "Douglas Neurosciences Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "10274.00", "debtors": "640.00", "cash_bank_in_hand": "100708.00", "current_assets": "101348.00", "creditors_due_within_one_year": "30108.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "71240.00", "total_assets_less_current_liabilities": "81514.00", "net_assets_liabilities": "81514.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "81414.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2020.zip" }, { "url": "/company/08354172/accounts/2019-01-31", "pdf_url": "/company/08354172/accounts/2019-01-31.pdf", "made_up_date": "2019-01-31", "period_start": "2019-01-31", "period_end": "2019-01-31", "entity_name": "Douglas Neurosciences Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "8624.00", "debtors": "764.00", "cash_bank_in_hand": "95191.00", "current_assets": "95955.00", "creditors_due_within_one_year": "38531.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "57424.00", "total_assets_less_current_liabilities": "66048.00", "net_assets_liabilities": "66048.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "65948.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2019.zip" }, { "url": "/company/08354172/accounts/2018-01-31", "pdf_url": "/company/08354172/accounts/2018-01-31.pdf", "made_up_date": "2018-01-31", "period_start": "2018-01-31", "period_end": "2018-01-31", "entity_name": "Douglas Neurosciences Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "7992.00", "debtors": "700.00", "cash_bank_in_hand": "73713.00", "current_assets": "74413.00", "creditors_due_within_one_year": "40400.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "34013.00", "total_assets_less_current_liabilities": "42005.00", "net_assets_liabilities": "42005.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "41905.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2018.zip" }, { "url": "/company/08354172/accounts/2017-01-31", "pdf_url": "/company/08354172/accounts/2017-01-31.pdf", "made_up_date": "2017-01-31", "period_start": "2017-01-31", "period_end": "2017-01-31", "entity_name": "Douglas Neurosciences Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "6309.00", "debtors": "475.00", "cash_bank_in_hand": "61520.00", "current_assets": "61995.00", "creditors_due_within_one_year": "37277.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "24718.00", "total_assets_less_current_liabilities": "31027.00", "net_assets_liabilities": "31027.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "30927.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2017.zip" }, { "url": "/company/08354172/accounts/2016-01-31", "pdf_url": "/company/08354172/accounts/2016-01-31.pdf", "made_up_date": "2016-01-31", "period_start": "2016-01-31", "period_end": "2016-01-31", "entity_name": "Douglas Neurosciences Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "3425.00", "debtors": "250.00", "cash_bank_in_hand": "29243.00", "current_assets": "29493.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "11983.00", "total_assets_less_current_liabilities": "15408.00", "net_assets_liabilities": "15408.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "15308.00", "shareholder_funds": "15408.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2016.zip" }, { "url": "/company/08354172/accounts/2015-01-31", "pdf_url": "/company/08354172/accounts/2015-01-31.pdf", "made_up_date": "2015-01-31", "period_start": "2015-01-31", "period_end": "2015-01-31", "entity_name": "Douglas Neurosciences Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "1396.00", "debtors": "250.00", "cash_bank_in_hand": "43097.00", "current_assets": "43347.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "21074.00", "total_assets_less_current_liabilities": "22470.00", "net_assets_liabilities": "22470.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "22370.00", "shareholder_funds": "22470.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2015.zip" }, { "url": "/company/08354172/accounts/2014-01-31", "pdf_url": "/company/08354172/accounts/2014-01-31.pdf", "made_up_date": "2014-01-31", "period_start": "2014-01-31", "period_end": "2014-01-31", "entity_name": "Douglas Neurosciences Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "63.00", "debtors": null, "cash_bank_in_hand": "4843.00", "current_assets": "4843.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1452.00", "total_assets_less_current_liabilities": "1515.00", "net_assets_liabilities": "1515.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "1514.00", "shareholder_funds": "1515.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2014.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08354172/filing-history" }, "confirmation_statement": { "next_due": "2027-01-23", "last_made_up": "2026-01-09" }, "officers": [], "psc": [ { "name": "Julie Louise Cassidy", "kind": "individual-person-with-significant-control", "person_url": "/person/2531336", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-07-01", "ceased_on": null, "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Dr Michael Richard Douglas", "kind": "individual-person-with-significant-control", "person_url": "/person/3364857", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-50-to-75-percent" ], "notified_on": "2016-07-01", "ceased_on": null, "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-14T22:50:00.959197+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }